Back to search
FDAFDA · Food and drugs·Recall number Z-2142-2026

Namic Preceptor Manifold, custom, Medline Product Number/SKU 64039307; Extravascular blood pressure transducer

Published May 20, 2026 · Recall initiated: March 24, 2026

Summary

FDA records medical device Class I recall Z-2142-2026, published May 20, 2026 and initiated March 24, 2026. Recalling firm: Medline Industries, LP; Status: Ongoing; Reported quantity: 760 units; Lot: UDI/DI each 10193489059205, UDI/DI case 30193489059209, Lot Numbers: 117277, 119982, 122210, 122199, 130129, 133014, 136396, 138613, 139138, 157974, 162399, 164317, 175538, 193515, 193531. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Medline has identified the presence of particulate within the fluid path of the Manifolds.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medline Industries, LP
Distributor
US (nationwide) and AE, AU, CA, JP, KR, NL, SG, SK.
Lot
UDI/DI each 10193489059205, UDI/DI case 30193489059209, Lot Numbers: 117277, 119982, 122210, 122199, 130129, 133014, 136396, 138613, 139138, 157974, 162399, 164317, 175538, 193515, 193531.
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Namic Preceptor Manifold, custom, Medline Product Number/SKU 64039307; Extravascular blood pressure transducer recalled?

Yes. FDA published recall Z-2142-2026 on May 20, 2026. Reported hazard: Medline has identified the presence of particulate within the fluid path of the Manifolds.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit